MyAverix Finance
US · Healthcare
Curative Biotechnology, Inc. (CUBTD)
Biotechnology
Curative Biotechnology, Inc. (CUBTD) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-22, reported market cap is $6.79M, P/E ratio is 25.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for CUBTD
Curative Biotechnology, Inc. (CUBTD) — FAQ
What is Curative Biotechnology, Inc.'s market cap?
Curative Biotechnology, Inc. (CUBTD) has a reported market cap of $6.79M (data as of 2026-05-22).
What is CUBTD's P/E ratio?
The price-to-earnings (P/E) ratio for Curative Biotechnology, Inc. (CUBTD) is 25.00 (data as of 2026-05-22).
Does Curative Biotechnology, Inc. pay a dividend?
Dividend yield is not available in the current snapshot for Curative Biotechnology, Inc. (CUBTD). Check the MyAverix Finance app for the latest dividend data.
What sector is Curative Biotechnology, Inc. in?
Curative Biotechnology, Inc. (CUBTD) is classified in the Healthcare sector (Biotechnology industry).
What exchange is CUBTD listed on?
CUBTD is listed on US.
What is Curative Biotechnology, Inc.'s net margin?
Curative Biotechnology, Inc. (CUBTD) reports a net margin of 0.0% (data as of 2026-05-22).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.